Elaya Inc.

elaya.ai

Elaya.ai develops innovative solutions for physiotherapy delivery in the ICU, focusing on neuromuscular electrical stimulation therapy to prevent ICU-acquired weakness (ICUAW). Their technology aims to improve patient outcomes and quality of life post-ICU by enabling effective therapy delivery to multiple patients and providing insights for personalized care. With a significant market need due to the high costs associated with long-term ventilation survivors, Elaya.ai positions itself as a key player in enhancing rehabilitation in critical care settings.